Don E. Griswold
- Immunology top 1%
- Immune Response and Inflammation 17
- Immune Cell Function and Interaction 12
- Mast cells and histamine 8
- Immunology and Allergy top 1%
- Physiology top 2%
- Asthma and respiratory diseases 20
- Oncology top 2%
- Cytokine Signaling Pathways and Interactions 16
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects 17
-
- Synthesis and biological activity 14
-
- Neuropeptides and Animal Physiology 8
- Co-authors
- Jerry L. AdamsEdward F. WebbBartholomew J. VottaJohn C. LeeDavid C. UnderwoodA M BadgerPeter R. YoungJeremy N. Bradbeer
- Journals
- Journal of Pharmacology and Experimental Therapeutics (9 papers)Journal of Medicinal Chemistry (8 papers)Cellular Immunology (5 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Don E. Griswold
120 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 128
- Immunology 2.0k
- Immunology and Allergy 413
- Physiology 1.2k
- Oncology 1.2k
- Pharmacology 628
Countries citing papers authored by Don E. Griswold
This map shows the geographic impact of Don E. Griswold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don E. Griswold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don E. Griswold more than expected).
Fields of papers citing papers by Don E. Griswold
This network shows the impact of papers produced by Don E. Griswold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don E. Griswold. The network helps show where Don E. Griswold may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Don E. Griswold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 73 | |
| 2 | 2006 | 11 | |
| 3 | Anti-CCL-2 / MCP-1 (monocyte chemoattractant protein-1) monoclonal antibodies effectively inhibit tumor angiogenesis and growth of human breast carcinoma | 2005 | 3 |
| 4 | 2005 | 31 | |
| 5 | 2005 | 73 | |
| 6 | 2004 | 10 | |
| 7 | 2000 | 186 | |
| 8 | 2000 | 386 | |
| 9 | 2000 | 281 | |
| 10 | 1999 | 68 | |
| 11 | 1998 | 88 | |
| 12 | 1998 | 341 | |
| 13 | 1998 | 17 | |
| 14 | 1997 | 31 | |
| 15 | 1997 | 112 | |
| 16 | 1996 | 11 | |
| 17 | 1995 | 2 | |
| 18 | 1994 | 38 | |
| 19 | 1991 | 3 | |
| 20 | 1987 | 68 |
About Don E. Griswold
Don E. Griswold is a scholar working on Immunology, Immunology and Allergy, Pharmacology, Oncology and Physiology, having authored 120 papers that have together received 6.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (20 papers), Inflammatory mediators and NSAID effects (17 papers), Immune Response and Inflammation (17 papers), Cytokine Signaling Pathways and Interactions (16 papers), Synthesis and biological activity (14 papers), Immune Cell Function and Interaction (12 papers), Neuropeptides and Animal Physiology (8 papers) and Mast cells and histamine (8 papers). The work is most often cited by research in Immunology (2.0k citations), Immunology and Allergy (413 citations), Physiology (1.2k citations), Oncology (1.2k citations) and Pharmacology (628 citations). Don E. Griswold has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jerry L. Adams, Edward F. Webb, Bartholomew J. Votta, John C. Lee, David C. Underwood, A M Badger, Peter R. Young, Jeremy N. Bradbeer, Douglas W.P. Hay and Nabil Hanna. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Medicinal Chemistry, Cellular Immunology, The Journal of Immunology and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.